Cochrane Clinical Answers - Access Denied - In preterm infants with bronchopulmonary dysplasia, what are the benefits and harms of initiating treatment with inhaled corticosteroids after the first week of life?

Question:In preterm infants with bronchopulmonary dysplasia, what are the benefits and harms of initiating treatment with inhaled corticosteroids after the first week of life?

THIS CLINICAL ANSWER IS ARCHIVED

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer evaluates late (treatment initiated at ≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.